3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Polycystic Ovary Syndrome
9
Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Prostatic Neoplasms
2
Neoplasms
2
Leukoplakia, Oral
2
Erythroplasia
2
Endometrial Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Urothelial Cancer
1
TP53 Y220C Mutation
1
Sarcoma
1
Rectal Neoplasms
1
Prostate Cancer Recurrent
1
Prediabetic State
1
Posterior Fossa Ependymal Tumor
1
Pleural Effusion, Malignant
1
Ovarian Neoplasms
1
Obesity
1
Neoplasms by Site
1
Mouth Neoplasms
1
Metabolic Diseases
1
Melanoma
1
Medulloblastoma
1
Insulin Resistance
1
Infertility
1
Hyperplasia
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
Interventions
Rituximab
9
venetoclax
7
ibrutinib
7
Cyclophosphamide
7
Mycophenolic Acid
5
fludarabine phosphate
4
Whole-Body Irradiation
4
Sirolimus
4
zanubrutinib
3
pirtobrutinib
3
Peripheral Blood Stem Cell Transplantation
3
Dexamethasone
3
Cyclosporine
3
ixazomib
2
fludarabine
2
carfilzomib
2
acalabrutinib
2
Tacrolimus
2
Melphalan
2
Etoposide
2
Cyclosporins
2
Calcium Dobesilate
2
CT-P10
2
Busulfan
2
Bendamustine Hydrochloride
2
talquetamab
1
pembrolizumab
1
loncastuximab tesirine
1
brexucabtagene autoleucel
1
Vincristine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Waldenstrom Macroglobulinemia
×
Metformin
×
90 days
×
Clear all
No trials found.